Limbaro, Rolando H.
HRN: 10-49-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
CEFTRIAXONE 1G (VIAL)
12/14/2025
12/21/2025
IV
2gm
OD
CAP-MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes